Login / Signup

Real-world effectiveness of brentuximab vedotin in the treatment of CD30-positive cutaneous T-cell lymphoma: a single-centre retrospective review.

Meagan-Helen Henderson BergK DavisonG Popradi
Published in: The British journal of dermatology (2021)
Keyphrases
  • hodgkin lymphoma
  • randomized controlled trial
  • systematic review
  • combination therapy